Author Correction: Tumour lineage shapes BRCA-mediated phenotypes

Philip Jonsson; Chaitanya Bandlamudi; Michael L Cheng; Preethi Srinivasan; Shweta S Chavan; Noah D Friedman; Ezra Y Rosen; Allison L Richards; Nancy Bouvier; S Duygu Selcuklu; Craig M Bielski; Wassim Abida; Diana Mandelker; Ozge Birsoy; Liying Zhang; Ahmet Zehir; Mark T A Donoghue; José Baselga; Kenneth Offit; Howard I Scher; Eileen M O'Reilly; Zsofia K Stadler; Nikolaus Schultz; Nicholas D Socci; Agnes Viale; Marc Ladanyi; Mark E Robson; David M Hyman; Michael F Berger; David B Solit; Barry S Taylor

doi:10.1038/s41586-019-1839-2

Author Correction: Tumour lineage shapes BRCA-mediated phenotypes

Nature. 2020 Jan;577(7789):E1. doi: 10.1038/s41586-019-1839-2.

Authors

Philip Jonsson^{1

2

3}, Chaitanya Bandlamudi¹, Michael L Cheng^{4

5}, Preethi Srinivasan⁶, Shweta S Chavan¹, Noah D Friedman^{2

3}, Ezra Y Rosen⁴, Allison L Richards¹, Nancy Bouvier¹, S Duygu Selcuklu¹, Craig M Bielski^{1

2

3}, Wassim Abida⁴, Diana Mandelker⁶, Ozge Birsoy⁶, Liying Zhang⁶, Ahmet Zehir⁶, Mark T A Donoghue¹, José Baselga^{4

7}, Kenneth Offit⁴, Howard I Scher⁴, Eileen M O'Reilly⁴, Zsofia K Stadler⁴, Nikolaus Schultz^{1

3}, Nicholas D Socci¹, Agnes Viale¹, Marc Ladanyi^{2

6}, Mark E Robson⁴, David M Hyman^{4

8}, Michael F Berger^{9

10

11}, David B Solit^{12

13

14

15}, Barry S Taylor^{16

17

18

19}

Affiliations

¹ Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Dana-Farber Cancer Institute, Boston, MA, USA.
⁶ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ AstraZeneca, Waltham, MA, USA.
⁸ Weill Cornell Medical College, New York, NY, USA.
⁹ Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.
¹⁰ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bergerm1@mskcc.org.
¹¹ Weill Cornell Medical College, New York, NY, USA. bergerm1@mskcc.org.
¹² Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.
¹³ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.
¹⁴ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. solitd@mskcc.org.
¹⁵ Weill Cornell Medical College, New York, NY, USA. solitd@mskcc.org.
¹⁶ Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.
¹⁷ Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.
¹⁸ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. taylorb@mskcc.org.
¹⁹ Weill Cornell Medical College, New York, NY, USA. taylorb@mskcc.org.

PMID: 31822847
DOI: 10.1038/s41586-019-1839-2

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum